Last updated: 2026-10-13 12:28:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Lyra Therapeutics, Inc. (LYRA) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0.00, with a market capitalisation of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.00 to $7.97. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
$1,100.00 | |
$0.00 | |
$0.68 | |
-- | |
9.39K | |
-- | |
$7.97 | |
$0.00 | |
-- | |
-- |
Lyra Therapeutics, Inc. (LYRA) is trading at $-- in pre-market trading as of --, -- from the previous close of $0.68
Pre-market trading shows how investors are pricing LYRA before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.
Over the past seven days, Lyra Therapeutics, Inc. (LYRA) moved from $0.03 to $0.68, representing a gain of 2,166.67% ($0.65).
The stock traded between $0.00 and $0.20 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 1.36 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.0%
LYRA is currently trading at $0.00, placing it 0.0% of the way from its 52-week low of $0.00 to its 52-week high of $7.97. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
LYRA THERAPEUTICS INC
| Exchange | NASDAQ |
Eligible investors can buy real shares of Lyra Therapeutics, Inc. (LYRA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.